Kyle Rose
Stock Analyst at Canaccord Genuity
(2.69)
# 2,048
Out of 4,945 analysts
114
Total ratings
53.26%
Success rate
13.73%
Average return
Main Sectors:
Stocks Rated by Kyle Rose
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SNN Smith & Nephew | Maintains: Hold | $27 | $36.60 | -26.23% | 6 | Feb 26, 2025 | |
| PODD Insulet | Maintains: Buy | $304 → $324 | $309.29 | +4.76% | 16 | Feb 21, 2025 | |
| SYK Stryker | Maintains: Buy | $420 → $435 | $374.92 | +16.03% | 20 | Jan 29, 2025 | |
| GMED Globus Medical | Maintains: Buy | $67 → $71 | $60.67 | +17.03% | 7 | Dec 20, 2023 | |
| ENOV Enovis | Maintains: Buy | $65 → $71 | $29.06 | +144.32% | 3 | Dec 20, 2023 | |
| INMD InMode | Downgrades: Hold | $55 → $22 | $14.31 | +53.74% | 10 | Oct 13, 2023 | |
| SKIN The Beauty Health Company | Assumes: Buy | $10 | $2.25 | +344.44% | 4 | Aug 25, 2023 | |
| ATEC Alphatec Holdings | Maintains: Buy | $17 → $22 | $15.46 | +42.30% | 4 | Aug 4, 2023 | |
| DXCM DexCom | Maintains: Buy | $135 → $150 | $79.11 | +89.61% | 17 | Jul 28, 2023 | |
| RBOT Vicarious Surgical | Maintains: Buy | $360 → $270 | $7.66 | +3,424.80% | 3 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $27 | $15.38 | +75.61% | 3 | May 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $1.44 | +941.67% | 1 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $14.40 | +4.17% | 6 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $125 → $122 | $182.26 | -33.06% | 1 | Mar 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $3 → $4 | $4.14 | -3.26% | 4 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $7.24 | - | 2 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $165 → $125 | $101.95 | +22.61% | 7 | Feb 8, 2022 |
Smith & Nephew
Feb 26, 2025
Maintains: Hold
Price Target: $27
Current: $36.60
Upside: -26.23%
Insulet
Feb 21, 2025
Maintains: Buy
Price Target: $304 → $324
Current: $309.29
Upside: +4.76%
Stryker
Jan 29, 2025
Maintains: Buy
Price Target: $420 → $435
Current: $374.92
Upside: +16.03%
Globus Medical
Dec 20, 2023
Maintains: Buy
Price Target: $67 → $71
Current: $60.67
Upside: +17.03%
Enovis
Dec 20, 2023
Maintains: Buy
Price Target: $65 → $71
Current: $29.06
Upside: +144.32%
InMode
Oct 13, 2023
Downgrades: Hold
Price Target: $55 → $22
Current: $14.31
Upside: +53.74%
The Beauty Health Company
Aug 25, 2023
Assumes: Buy
Price Target: $10
Current: $2.25
Upside: +344.44%
Alphatec Holdings
Aug 4, 2023
Maintains: Buy
Price Target: $17 → $22
Current: $15.46
Upside: +42.30%
DexCom
Jul 28, 2023
Maintains: Buy
Price Target: $135 → $150
Current: $79.11
Upside: +89.61%
Vicarious Surgical
May 31, 2023
Maintains: Buy
Price Target: $360 → $270
Current: $7.66
Upside: +3,424.80%
May 2, 2023
Maintains: Buy
Price Target: $24 → $27
Current: $15.38
Upside: +75.61%
Mar 28, 2023
Reiterates: Buy
Price Target: $15
Current: $1.44
Upside: +941.67%
Mar 28, 2023
Reiterates: Buy
Price Target: $15
Current: $14.40
Upside: +4.17%
Mar 1, 2023
Maintains: Market Perform
Price Target: $125 → $122
Current: $182.26
Upside: -33.06%
Nov 10, 2022
Upgrades: Buy
Price Target: $3 → $4
Current: $4.14
Upside: -3.26%
Nov 9, 2022
Downgrades: Hold
Price Target: n/a
Current: $7.24
Upside: -
Feb 8, 2022
Downgrades: Hold
Price Target: $165 → $125
Current: $101.95
Upside: +22.61%